↠´ Read ↠´ Bottle of Lies by Katherine Eban Õ itelemedicine.pro

↠´ Read ↠´ Bottle of Lies by Katherine Eban Õ Never again will I swallow a new pill without finding out where the thing was manufactured Katherine Eban s devastating account of fraud in the generic drug industry is equally damning to the compromises that our regulators make in response to political demands for low cost medication Please do whatever you can to make sure your physician, your pharmacist, and your members of Congress read this book I am not greatly surprised that deception is widely practiced in the Indian drug industry, but I am shocked and greatly disappointed that our own Food and Drug Administration has relaxed its vigilance over the standards under which generic medicines are made even in our own country This needs to be corrected, ASAP.
Eban deserves congratulation not only Katherine Eban is an investigative reporter focusing on the pharmaceutical industry for many years.
In 2008, Joe Graedon, a host of the NPR program The People s Pharmacy, contacted Katherine Eban Patients had been calling and writing in to his program with serious complaints about generic drugs that either didn t work or caused devastating side effects Patients who had previously been stabilized on brand name drugs relapsed when switched to certain generics He wanted to know whether generics were equivalent to the brand This book is the result of that question.
Prior to 1984, generic companies of the world had no way to challenge the brand name drugs There was no clear pathway for a generic drug to be approved in the United States Under FDA rules, even if a drug s patent had expired, generic drug companies w Here is an important, easily read, current book with essential information we collectively need to prioritize rethinking of pharmaceutical ethics, manufacturing, delivery, politics, guidelines, and economics worldwide I strongly encourage those interested in public health, policy making, regulatory affairs, and global vision to hear Eban s story I also encourage all involved in pharmaceutical manufacturing to learn about integrity, the health consequences of short cuts, and ethical problem solving The term, ethical drug, traditionally means a pharmaceutical requiring a prescription The people who make medicines must have accountability and ethics, yet this is not the default case Many ethical drugs are not ethically made at all Money, greed, societal pressures, a In a world where pharmaceutical companies charge thousands of dollars for life saving medicines that cost under a dollar to make and whose development was paid for by the taxpayer, inexpensive generics threaten to undercut prices and eliminate outrageous return on investment Only one woman stood up to defend billionaire CEO s and rent seeking shareholders That hero wrote this book.
I urge everyone I know to read this account of generic drug manufacturing in India and China When you do you will run to your medicine cabinet and check every bottle This is sobering and sad as it is another illustration of humankind s love of profit and lack of love for everyone else It will also give you hope because there remain whistleblowers with courage and conviction whose affection and concern for their fellow man trumps greed, not to mention the dedication of this journalist for shining light on the issue.



What is worse than a drug with a lot of side effects A drug with only a lot of side effects.
A scintillating read into the evolution of global generic drug industry and its transgressions.
The author doesn t pull any punches intended for the astoundingly criminal lack of integrity and regulatory oversight in the generic pharmaceutical industry.
From an author s point of view, what could have been a simple, boring collection of news articles, she did a commendable job in describing the quality and integrity or the lack of it in the Indian pharmaceutical companies through the prism of the Ranbaxy debacle She also underscores the intricacies of congressional pressure to keep drug costs down by approving generics along with the lack of authority the FDA possesses once outsi Amazing storytelling, at par with books like Den of thieves or Enron story May seem a biased against generic pharma but enough lessons for those willing to take a constructive viewpoint Lots of respect Mr Thakur, what a person May the forces with you.
This is a must read book for anyone who has been prescribed a generic medication which is pretty much everyone The book is long and may look intimidating, but it reads like an action thriller There are heroes and villains, conspiracies involving presidents of companies , and chases although they probably weren t high speed as they usually involved bench analytical chemists who mostly sit in front of a computer all day.
The amount of research and number of interviews that were necessary to put together this excellent example of investigative reporting is impressive My only gripe and it is really of a pet peeve since I work on them for a living is that the author refers to HPLCs as machines They are not machines, they are instruments, because they m I have been studying the pharma industry for the last couple of months from the ground up and this book couldn t have come at a better time Needless to say, I bought a copy the day it was released The recent media reports over the generics price fixing scandal gave it good publicity as well.
The book is a stunning expose of the dark underbelly of the global generics industry, of which India and China are the powerhouses These two countries are also the most notorious in terms of non compliance to regulations if the author is to be believed One may question if generics makers at other places outside of the US fare any better but that s not the point What is of foremost importance is whether the medicine we are ingesting is actually helping us get better Worse, is it actuall A NEW YORK TIMES BESTSELLER From An Award Winning Journalist, An Explosive Narrative Investigation Of The Generic Drug Boom That Reveals Fraud And Life Threatening Dangers On A Global Scale The Jungle For PharmaceuticalsMany Have Hailed The Widespread Use Of Generic Drugs As One Of The Most Important Public Health Developments Of The Twenty First Century Today, Almost Percent Of Our Pharmaceutical Market Is Comprised Of Generics, The Majority Of Which Are Manufactured Overseas We Have Been Reassured By Our Doctors, Our Pharmacists And Our Regulators That Generic Drugs Are Identical To Their Brand Name Counterparts, Just Less Expensive But Is This Really True Katherine Eban S Bottle of Lies Exposes The Deceit Behind Generic Drug Manufacturing And The Attendant Risks For Global Health Drawing On Exclusive Accounts From Whistleblowers And Regulators, As Well As Thousands Of Pages Of Confidential FDA Documents, Eban Reveals An Industry Where Fraud Is Rampant, Companies Routinely Falsify Data, And Executives Circumvent Almost Every Principle Of Safe Manufacturing To Minimize Cost And Maximize Profit, Confident In Their Ability To Fool Inspectors Meanwhile, Patients Unwittingly Consume Medicine With Unpredictable And Dangerous EffectsThe Story Of Generic Drugs Is Truly Global It Connects Middle America To China, India, Sub Saharan Africa And Brazil, And Represents The Ultimate Litmus Test Of Globalization What Are The Risks Of Moving Drug Manufacturing Offshore, And Are They Worth The Savings A Decade Long Investigation With International Sweep, High Stakes Brinkmanship And Big Money At Its Core, Bottle of Lies Reveals How The World S Greatest Public Health Innovation Has Become One Of Its Most Astonishing Swindles

Katherine Eban, an investigative journalist, is a Fortune magazine contributor and Andrew Carnegie fellow Her articles on pharmaceutical counterfeiting, gun trafficking, and coercive interrogations by the CIA, have won international attention and numerous awards She lectures frequently on the topic of pharmaceutical integrity Bottle of Lies The Inside Story of the Generic Drug Boom, which she